These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20206839)

  • 61. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Parsa AA; New MI
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):2-11. PubMed ID: 27380651
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnosis and management of congenital adrenal hyperplasia: 20-year experience in Songklanagarind Hospital.
    Jaruratanasirikul S; Thongseiratch T
    J Med Assoc Thai; 2013 Mar; 96(3):288-93. PubMed ID: 23539930
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genotype in the diagnosis of 21-hydroxylase deficiency: who should undergo CYP21A2 analysis?
    Cavarzere P; Vincenzi M; Teofoli F; Gaudino R; Lauriola S; Maines E; Camilot M; Antoniazzi F
    J Endocrinol Invest; 2013 Dec; 36(11):1083-9. PubMed ID: 24081139
    [TBL] [Abstract][Full Text] [Related]  

  • 64. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Challenges of CYP21A2 genotyping in children with 21-hydroxylase deficiency: determination of genotype-phenotype correlation using next generation sequencing in Southeastern Anatolia.
    Karaoğlan M; Nacarkahya G; Aytaç EH; Keskin M
    J Endocrinol Invest; 2021 Nov; 44(11):2395-2405. PubMed ID: 33677812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutations in steroid 21-hydroxylase (CYP21).
    White PC; Tusie-Luna MT; New MI; Speiser PW
    Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pregnancy outcomes of eight pregnant women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    Yu H; Bian XM; Liu JT; Hu XY; Zhou Q
    Zhonghua Fu Chan Ke Za Zhi; 2012 Sep; 47(9):651-4. PubMed ID: 23141285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.
    Nimkarn S; Cerame BI; Wei JQ; Dumic M; Zunec R; Brkljacic L; Skrabić V; New MI; Wilson RC
    J Clin Endocrinol Metab; 1999 Jan; 84(1):378-81. PubMed ID: 9920112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S; Sellers EA; Guyda H;
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype.
    Wilson RC; Mercado AB; Cheng KC; New MI
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2322-9. PubMed ID: 7629224
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China.
    Su L; Yin X; Cheng J; Cai Y; Wu D; Feng Z; Liu L
    Clin Chim Acta; 2018 Nov; 486():142-150. PubMed ID: 30048636
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Congenital adrenal hyperplasia: diagnostic advances.
    Torresani T; Biason-Lauber A
    J Inherit Metab Dis; 2007 Aug; 30(4):563-75. PubMed ID: 17694353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
    Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
    Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
    Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
    J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Molecular characterization of mutations and phenotype/genotype correlation in Chinese patients with 21-hydroxylase deficiency].
    Zhang B; Lu ZL; Wang Y; Tao H
    Yi Chuan Xue Bao; 2004 Sep; 31(9):950-5. PubMed ID: 15493145
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B; Feuillan P; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosis and management of classical congenital adrenal hyperplasia.
    Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
    Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between genotype, clinical presentation, and severity of congenital adrenal hyperplasia: a review.
    Al-Agha AE; Ocheltree AH; Al-Tamimi MD
    Turk J Pediatr; 2012; 54(4):323-32. PubMed ID: 23692712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Refractory acne and 21-hydroxylase deficiency in a selected group of female patients.
    Caputo V; Fiorella S; Curiale S; Caputo A; Niceta M
    Dermatology; 2010; 220(2):121-7. PubMed ID: 20110635
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Adrenal hyperplasia as a result of 21-hydroxylase deficiency: prenatal diagnosis and treatment. Neonatal diagnosis].
    Lambotte C
    Rev Med Liege; 1986 Jan; 41(2):37-44. PubMed ID: 3006204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.